Although more detailed studies on the mechanisms by which HJURP promotes HCC and CCA, as well as its impact on tumor immunogenicity, are warranted, these findings suggest that HJURP is a potential biomarker and therapeutic target for HCC and CCA. The gene discussed is HJURP; the disease is hepatocellular carcinoma.